Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM

Diabetologia

Volumn 39, Issue 1, 1996, Pages 60-69

  Hussain, M J ^a   Peakman, M ^a   Gallati, H ^d   Lo, S S S ^c   Hawa, M ^c   Viberti, G C ^b   Watkins, P J ^a   Leslie, R D G ^c   Vergani, D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Cytokines; Identical twins; Interferon ; Interleukin 1; Interleukin 2; Prediabetes; T helper subsets; Tumour necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONOZYGOTIC TWINS; PATHOGENESIS; PRIORITY JOURNAL;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASES IN TWINS; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; GRAVES DISEASE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; MACROPHAGES; PREDIABETIC STATE; PROSPECTIVE STUDIES; REFERENCE VALUES; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA; TWINS, MONOZYGOTIC;

EID: 0030030135     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Leslie RDG, Lazarus NR, Vergani D (1989) Aetiology of insulin dependent diabetes. Brit Med Bull 45: 58-72
2. Gepts W (1965) Pathological anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619-633
3. Bottazzo GF, Dean BM, McNally JM, Mackay EH; Swift PGF, Gamble DR (1985) In situ characterization of au-toimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313; 353-360
4. Foulis AK, Megill M, Farquharson MA (1991) Insulitis in type 1 (insulin-dependent diabetes mellitus in man - macrophages, lymphocytes, and interferon-γ containing cells. J Pathol 165: 97-103
5. Hänninen A, Jalkanen S, Salmi M, Toikkannen S, Nikolakaros G, Simell O (1992) Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90: 1901-1910
6. Lee KU, Amano K, Yoon JW (1988) Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37: 989-991
7. Dinarello CA, Mier JW (1987) Lymphokines. N Engl J Med 317: 940-945
8. Mandrup-Poulson T, Helqvist S, Mølvig J, Wogensen LD, Nerup J (1989) Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 10: 241-253
9. Rabinovitch A (1993) Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev 1: 215-240
10. Mandrup-Poulson T, Benutzen K, Dinarello CA, Nerup J (1987) Human tumour necrosis factor potentiates human interleukin-1 mediated rat pancreatic β-cell cytotoxicity. J Immunol 139: 4077-4082
11. Pujol-Borrell R, Todd I, Doshi M, et al. (1987) HLA class II induction human islet cells by interferon-β plus TNF-α or lymphotoxin. Nature 326: 304-306
12. Soldevila G, Buscema M, Doshi M, James RFL, Bottazzo GF, Pujol-Borrell R (1991) Cytotoxic effect of IFN-γ plus TNF-α on human islet cells. J Autoimmun 4: 291-306
13. Nicoletti F, Meroni PL, Landolfo S, et al. (1990) Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon gamma. Lancet 336: 319
14. Campbell IL, Kay TWH, Oxbrow L, Harrison LC (1991) Essential role of interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87: 739-742
15. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H (1990) Prevention of diabetes in nonobese diabetic mice by tumour necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 87: 968-972
16. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357
17. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173
18. H2 subsets: doubt no more. Immunol Today 12: 256-257
19. Harrison LC, Honeyman MC, De Aizpurua HJ, et al. (1993) Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365-1369
20. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057
21. Olmos P, A'Hern P, Heaton DA, et al. (1988) The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31: 747-750
22. Senaldi G, Peakman M, Natoli C, et al. (1994) Relationship between the tumour associated antigen 90K and cytokines in the circulation of patients with human immunodeficiency virus infection. J Infection 28: 31-35
23. Gallati H, Pracht I, Schmidt J, Häring P, Garotta G (1987) Simple, rapid and large capacity ELISA for biologically active native and recombinant human IFN-γ. J Biol Regul Homeost Agents 1: 109-118
24. Gillis S, Ferm MM, Ou W, Smith KA (1978) T cell growth factor parameters of production and quantitative microassay for activity. J Immunol 120: 2027-2032
25. Helle M, Brakenhoff JP, De Groot ER, Aarden LA (1988) Interleukin-6 is involved in interleukin-1-induced activities. Eur J Immunol 18: 957-959
26. Kaye WA, Adri MNS, Soeldner JS, et al. (1986) Acquired defect in IL-2 production in patients with IDDM. N Engl J Med 315: 920-924
27. Meager A, Parti S, Leung H, Peil E, Mahon B (1987) Preparation and characterization of monoclonal antibodies directed against antigenetic determinants of recombinant human tumour necrosis factor. Hybridoma 6: 305-311
28. Bonifacio E, Bingley P, Shattock M et al. (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147-149
29. Christie MR, Tun RYM, Lo SSS, et al. (1992) Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Diabetes 41: 782-787
30. Kaufman DL, Clare-Salzer M, Tian J, et al. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72
31. Trinchieri G, Perussia B (1985) Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 6: 131-136
32. Henke A, Mohr C, Sprenger H, et al. (1992) Coxsackievirus B3-induced production of tumour necrosis factor-α, IL-1 β, and IL-6 in human monocytes. J Immunol 148: 2270-2277
33. Cavallo MG, Pozzilli P, Bird C, et al. (1991) Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 86: 256-259
34. Tovo PA, Cerutti F, Palomha E, Salomonc C, Pugliese A (1984) Evidence of circulating interferon-gamma in newly diagnosed diabetic children. Acta Paediatr Scand 73: 785-788
35. Espersen GT, Mathiesen O, Grunnet N, Jensen S, Ditzel J (1993) Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment. APMIS 101: 703-706
36. Mooradian AD, Reed RL, Meredith KE, Scuderi P (1991) Serum levels of tumour necrosis factor and IL-1 α and IL-1 β in diabetic patients. Diabetes Care 14: 63-65
37. Scott KD, Daniel GQ, Kathrin M (1991) New cytokines and receptors make their debut in San Antonio. Immunol Today 12: 54-57
38. Sandler S, Bendtzen K, Borg LAH, Eizirik DL, Strandell E, Welsh N (1989) Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 β indicate a perturbation in the mitochondrial function. Endocrinology 124: 1492-1501
39. Eizirik DL, Bendtzen K, Sandler S (1991) Short exposure of rat pancreatic islets to interleukin-1 β induces a sustained but reversible impairment in β-cell function: influence of protease activation, gene transcription, and protein synthesis. Endocrinology 128: 1611-1616
40. Walker R, Bone AJ, Cooke A, Baird DJ (1988) Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats: possible role for macrophages in pathogenesis of IDDM. Diabetes 37: 1301-1304
41. Oschilewski U, Kiesel U, Kolb H (1985) Administration of silica prevents diabetes in BB-rats. Diabetes 34: 197-199
42. Fowell D, Mason D (1993) Evidence that the T-cell repertoire of normal rats contains cells with the potential to cause diabetes: characterisation of CD4+ T-cell subset that inhibits the autoimmune potential. J Exp Med 177: 627-636
43. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11: 165-190
44. Cheung DL, Hart PH, Vitti GF, Whitty FA, Hamilton JA (1990) Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 71: 70-75
45. Rapoport MJ, Jaramillo A, Zipris D, et al. (1993) IL-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in NOD mice. J Exp Med 178: 87-99
46. Pennline KJ, Roque-Gaffney E, Monahan P (1994) Recombinant human IL-10 (rHU IL-10) prevents the onset of diabetes in the non-obese diabetic (NOD) mouse. Clin Immunol Immunopathol 71: 169-175
47. Rabinovitch A (1994) Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 43: 613-621
48. Gilbey SC, Hussain MJ, Watkins PJ, Vergani D (1988) Cell-mediated immunity and symptomatic diabetic autonomic neuropathy. Diabet Med 5: 845-848
49. Bending JJ, Lobo-Yeo A, Vergani D, Viberti GC (1988) Proteinuria and activated T lymphocytes in diabetic nephropathy. Diabetes 37: 507-511